We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Illustration

Novel Coronavirus Could Be Targeting Kidneys, Suggests New Data

 New data on the coronavirus disease has revealed that kidney involvement appears to be frequent in people who have tested positive and developed symptoms. Proteinuria (and/or blood in urine) often occurs at the beginning or during the infection, with a few patients even developing acute kidney injury (AKI), thus indicating that COVID-19 also attacks the kidneys. Given the involvement of kidneys during coronavirus infection, patients should also be monitored after the disease. More...
19 Mar 2020
Image: SARS-CoV-2 synthetic RNA Controls (RUO) now available (Photo courtesy of Microbiologics, Inc.)

Microbiologics Introduces SARS-CoV-2 Synthetic RNA for COVID-19 Research

 Microbiologics, Inc. (Saint Cloud, MN, USA) has prepared synthetic RNA for SARS-CoV-2 to assist in the efforts to monitor the spread of COVID-19. More...
18 Mar 2020
Image: STAT-NAT® COVID-19 Assay (Photo courtesy of Sentinel Diagnostics)

Sentinel Diagnostics Develops Ready-To-Use Real-Time PCR Mix for Detection of Novel Coronavirus

 Sentinel Diagnostics (Milan, Italy) has announced that it has developed a ready-to-use Real-Time PCR mix for the detection of novel Coronavirus disease (COVID-19). Sentinel has developed two kits in collaboration with the most important hospital lab for the detection and treatment of coronavirus in Italy. More...
18 Mar 2020
Image: Allplex™ 2019-nCoV Assay (Photo courtesy of Seegene Inc.)

Seegene Launches KFDA-Approved COVID-19 Assay

 Seegene Inc. (Seoul, South Korea) has received approval from the Korea Ministry of Food and Drug Safety for its novel coronavirus (COIVD-19) Real-time PCR assay for emergency use, following the recent obtaining of CE-IVD Mark. The company has begun offering the assays in Korea and across the world. More...
18 Mar 2020
Illustration

Israeli Scientists to Announce Development of Coronavirus Vaccine

 Over 50 experienced PhD scientists from the Israel Institute for Biological research (IIBR; Ness-Ziona, Israel) are working to produce a vaccine and antibody for the novel coronavirus. More...
16 Mar 2020

Preventive Measures Detain Nosocomial Coronavirus Transmission

 Meticulous application of best practices for infection control can help protect healthcare workers from coronavirus disease (COVID-19), according to a new study. More...
16 Mar 2020
Illustration

Researchers Discover World’s First Human Antibody that Could Inhibit New Coronavirus (SARS-CoV-2)

 Researchers have developed the world’s first human antibody that could inhibit the new coronavirus (SARS-CoV-2) and ‘offers potential for prevention and treatment of COVID-19’. A team of 10 scientists from the University of Utrecht (Utrecht, the Netherlands), the Erasmus Medical Centre (Rotterdam, the Netherlands), and biotech company Harbor BioMed (Cambridge, MA, USA) have published their research online on BioRxiv where it is under peer review before being published by the prestigious journal Nature. More...
14 Mar 2020
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Electric Cast Saw
CC4 System
New
Digital Radiographic System
OMNERA 300M